Vendor Alliances Heat Up at SBS Conference | GenomeWeb

GENEVA — At the Society for Biomolecular Screening conference, held here this week, cell-based assay technologies were represented more strongly than at any other time in the 11-year history of the meeting.

More than 300 scientific posters highlighted some of the most cutting-edge research being conducted in the drug screening industry today. The topics of these scientific posters covered a variety of contemporary drug-discovery technologies, but a growing number in particular focused on cell-based assay research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.